emegenresearch

  According to the current analysis of Emergen Research, the global Diabetic Ketoacidosis Market was valued at USD 1297.3 million in 2019 and is expected to reach USD 1973.6 million by 2027, at a CAGR of 6.2%. Increasing awareness among healthcare professionals about ketones build up during type 1 diabetes as well as type 2 diabetes, and favorable funding scenario for drug development and technological advancements in diabetes ketoacidosis treatment is anticipated to boost the growth of the market during the forecast period. Ketoacidosis, hyperglycemia and ketonuria during diabetic ketoacidosis makes it a critical life threatening condition of diabetes. Furthermore, growing prevalence of type 1 diabetes across the globe, increasing availability of well-organized and technologically advanced diabetic ketoacidosis treatment in developing nations, significant R&D activities by the existing and emerging market players to develop effective drugs in an attempt to cater the demand sup...

  The latest study on the Computerized Physician Order Entry CPOE Market industry includes a detailed analysis of the future trends and demands for the forecast period, 2024 -   2033 The study is inclusive of a profound analysis of this business sphere focuses on the overall remuneration of the market over the projected period. The study also includes significant information pertinent to the Computerized Physician Order Entry CPOE Market industry, particularly the current COVID-19 scenario. E xhaustive coverage of the COVID-19 impact on the Computerized Physician Order Entry CPOE Market industry is a major attraction of the report. The Computerized Physician Order Entry (CPOE) Market is expected to grow from an estimated USD 1,965.5 million in 2024 to USD 3,674.7 million in 2033, at a CAGR of 7.2%.The increasing need for better patient safety is fueling the expansion of the computerized physician order entry (CPOE) industry. Among many advantages that CPOE systems provide, on...